相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

834

胰腺癌中的DNA损伤修复突变 - 预后还是预测?

Ya-Fei Hu1, Hai-Jie Hu1, Heng-Chung Kung2

  • 1Department of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

Frontiers in oncology
|November 13, 2023
PubMed
概括

化疗改善了DNA损伤修复突变的晚期胰腺癌患者的生存率. 然而,对于切除的胰腺癌,辅助化疗在这些患者中显示出有限的有效性.

关键词:
DNA损伤修复基因修复基因总体存活率 总体存活率胰腺癌是一种癌症.基于的化学疗法.没有进展的生存率.

更多相关视频

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.2K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.4K

相关概念视频

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K